Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy

作者: W. Jeske , D. A. Hoppensteadt , R. Pifarre , J. M. Walenga , J. Fareed

DOI: 10.1007/978-3-642-51190-5_10

关键词: BioinformaticsMedicineAntithromboticCoagulationAnticoagulantWarfarinVenous thrombosisAntithrombinHeparinHemostasis

摘要: Hemostasis as defined by Virchow in the last century is a fine balance between blood flow, humoral factors, and cellular elements of vascular system. Today, biotechnology has advanced our understanding thrombotic process its regulation. Whereas past, heparin warfarin have been sole antithrombotic agents available, specific sites network at both plasmatic can now be targeted. Antibodies against platelet receptors well antithrombin anti-Xa are being developed. Mutations endogenous inhibitors identified causes congenital thrombophilias. The use also advanced. Heparin no longer solely surgical anticoagulant, but used to treat variety conditions including venous thrombosis, unstable angina, myocardial infarction procedures such angioplasty stent implantation. mechanism heparin’s action become more complex with discovery tissue factor pathway inhibitor, selectins, other targets where drug able produce effects.

参考文章(136)
E J Haskel, S R Torr, K C Day, M O Palmier, T C Wun, B E Sobel, D R Abendschein, Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. ,vol. 84, pp. 821- 827 ,(1991) , 10.1161/01.CIR.84.2.821
Shaun P. Jackson, Yuping Yuan, Simone M. Schoenwaelder, Christina A. Mitchell, Role of the platelet integrin glycoprotein IIb-IIIa in intracellular signalling. Thrombosis Research. ,vol. 71, pp. 159- 168 ,(1993) , 10.1016/0049-3848(93)90182-N
A. K. Lindahl, P. M. Sandset, U. Abildgaard, THE PRESENT STATUS OF TISSUE FACTOR PATHWAY INHIBITOR Blood Coagulation & Fibrinolysis. ,vol. 3, pp. 439- 449 ,(1992) , 10.1097/00001721-199203040-00011
SANFORD J. SHATTIL, Platelets and Their Membranes in Hemostasis: Physiology and Pathophysiology Annals of Internal Medicine. ,vol. 94, pp. 108- 118 ,(1981) , 10.7326/0003-4819-94-1-108
J. Fareed, J. M. Walenga, L. Iyer, D. Hoppensteadt, R. Pifarre, An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent. Blood Coagulation & Fibrinolysis. ,vol. 2, pp. 135- 147 ,(1991) , 10.1097/00001721-199102000-00021
S A Gregory, J H Morrissey, T S Edgington, Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Molecular and Cellular Biology. ,vol. 9, pp. 2752- 2755 ,(1989) , 10.1128/MCB.9.6.2752